A recent Brazilian study suggests that fish oil may play a key role in reducing insulin resistance and improving glucose tolerance, offering hope for non-obese individuals with type 2 diabetes.
A groundbreaking Brazilian study has revealed that fish oil supplementation could potentially reverse insulin resistance, particularly in non-obese individuals. The study, published in Nutrients, sheds new light on the relationship between omega-3 fatty acids and insulin resistance, offering hope for the 10%–20% of the global population with non-obese type 2 diabetes.
This preclinical research, funded by FAPESP, was conducted on Goto-Kakizaki (GK) rats, a model for non-obese type 2 diabetes. For eight weeks, rats were administered 2 grams of fish oil per kilogram of body weight, containing 540 mg/g of eicosapentaenoic acid (EPA) and 100 mg/g of docosahexaenoic acid (DHA). The results showed a remarkable reduction in insulin resistance, accompanied by improved blood sugar levels, lipid profiles, and inflammatory markers.
Omega-3 fatty acids have long been recognized for their cardiovascular benefits, but their impact on insulin resistance in non-obese individuals was poorly understood. This study is the first to demonstrate that fish oil supplementation can modulate immune cells—particularly lymphocytes—by shifting them from a pro-inflammatory to an anti-inflammatory state, thereby reversing insulin resistance.
Rui Curi, director of the Butantan Institute and coordinator of the study, explained that the findings suggest a potential link between inflammation and insulin resistance, even in the absence of obesity. The altered immune response seen in the GK rats parallels what is observed in obese individuals with insulin resistance, where immune cells like lymphocytes and macrophages produce pro-inflammatory cytokines.
The study further highlights the critical role of systemic inflammation in the development of insulin resistance. While obesity is a well-known risk factor, systemic inflammation in non-obese individuals may also contribute to the onset of type 2 diabetes. Curi suggests that the primary cause of insulin resistance in non-obese individuals could be genetic, and further research is necessary to explore the full range of factors contributing to the condition.
The study’s findings open new possibilities for treating non-obese type 2 diabetes patients, offering a potential therapeutic route that avoids the need for weight loss. This exciting research paves the way for further investigations into the impact of omega-3 fatty acids on diabetes and related metabolic conditions.
The researchers plan to continue studying the mechanisms behind insulin resistance in non-obese animals, expanding their understanding of how systemic inflammation influences diabetes. If future studies confirm the potential of fish oil in managing insulin resistance, it could revolutionize the way we treat diabetes and other inflammatory diseases.
Donald Trump has once again shared a video clip of Azerbaijani President Ilham Aliyev’s remarks from the Shusha Global Media Forum on his Truth Soci...
A Russian drone attack on Ukraine’s southern Odesa region has damaged an oil depot belonging to Azerbaijan’s state oil company, SOCAR, and left fo...
During President Ilham Aliyev’s visit to Washington, officials from Azerbaijan and the United States discussed expanding economic collaboration and ...
President Ilham Aliyev’s meetings with U.S. President Donald Trump and Armenian Prime Minister Nikol Pashinyan will be held at the White House today...
Belarusian President Alexander Lukashenko stated in an interview published on Friday that he has no intention of seeking another term in office and di...
Scientists in Australia and the U.S. have developed an AI tool that could transform cancer care by revealing the hidden diversity of tumour cells and guiding more targeted therapies.
On the sun-soaked southern tip of China, a new kind of medical tourism is quietly unfolding. It’s not about cosmetic surgery or wellness spas but about survival.
Researchers have developed a new testing method that could diagnose brain tumors within hours, potentially allowing treatment to begin during surgery.
Joe Biden has publicly thanked people around the world for their support after announcing he’s battling an aggressive form of prostate cancer.
The world’s biggest dance music festival faces an unexpected setback as a fire destroys its main stage, prompting a last-minute response from organisers determined to keep the party alive in Boom, Belgium.
According to the German Research Centre for Geosciences (GFZ), a magnitude 5.7 earthquake struck the Oaxaca region of Mexico on Saturday.
China and the Association of Southeast Asian Nations will send an upgraded ‘version 3.0’ free-trade agreement to their heads of government for approval in October, Chinese Foreign Minister Wang Yi said on Saturday after regional talks in Kuala Lumpur.
A resumption of Iraq’s Kurdish oil exports is not expected in the near term, sources familiar with the matter said on Friday, despite an announcement by Iraq’s federal government a day earlier stating that shipments would resume immediately.
Chinese automaker Chery has denied an industry-ministry audit that disqualified more than $53 million in state incentives for thousands of its electric and hybrid vehicles, insisting it followed official guidance and committed no fraud.
Tech giant Google has announced a $1 billion investment to support Artificial Intelligence (AI) education and research at universities across the United States.
What shapes human nature? Why do some people act with compassion while others turn cruel? For centuries, thinkers — from philosophers and playwrights to theologians and psychologists — have grappled with these timeless questions, searching for what lies at the heart of good and evil.
A new skin cancer drug has been developed using a genetically engineered virus that targets and replicates only cancer cells. That's according to public broadcaster NHK who said that researchers in Japan found that 77.8% of those tested, improved.
Adults are inhaling around 68,000 microplastic particles each day, researchers warn, over 100 times previous estimates.
Americans will soon be able to access and share their medical records through a new “digital health tech ecosystem”, unveiled by U.S. President Donald Trump in partnership with more than 60 major technology companies.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment